Benitec Biopharma Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

Benitec Biopharma Inc. is a biotechnology company operating in the research sector, focused on developing a therapeutic platform that combines RNA interference with gene therapy to achieve sustained silencing of disease-causing genes after a single administration. The company is advancing a pipeline of ddRNAi-based candidates aimed at chronic and life-threatening diseases, including oculopharyngeal muscular dystrophy and hepatitis B, with the potential to reduce the need for ongoing dosing. Based in Hayward, California, the organization positions itself within the gene therapy field, pursuing clinical validation and potential commercialization of ddRNAi therapeutics for diseases with high unmet clinical need or large patient populations. The business activity centers on translating its proprietary approach into treatments that address genetic disorders through targeted gene silencing, with public communications highlighting ongoing clinical work such as BB-301 for OPMD. In addition to its research focus, recent public disclosures indicate engagement with scientific and clinical communities through conferences and presentations.

Sign up for free to view info

Email Format Employee directory